Peng Liu

Dr. Peng Liu

Shanghai Center for Drug Evaluation and Inspection
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Peng LiuPeng Liu
Peng Liu
GCGuiliang Chen
Guiliang Chen
JZJingchen Zhang
Jingchen Zhang
Liposomes have been considered promising and versatile drug vesicles. Compared with traditional drug delivery systems, liposomes exhibit better properties, including site-targeting, sustained or controlled release, protection of drugs from degradation and clearance, superior therapeutic effects, and lower toxic side effects. Given these merits, several liposomal drug products have been successfully approved and used in clinics over the last couple of decades. In this review, the liposomal drug products approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) are discussed. Based on the published approval package in the FDA and European public assessment report (EPAR) in EMA, the critical chemistry information and mature pharmaceutical technologies applied in the marketed liposomal products, including the lipid excipient, manufacturing methods, nanosizing technique, drug loading methods, as well as critical quality attributions (CQAs) of products, are introduced. Additionally, the current regulatory guidance and future perspectives related to liposomal products are summarized. This knowledge can be used for research and development of the liposomal drug candidates under various pipelines, including the laboratory bench, pilot plant, and commercial manufacturing.

22 August 2014 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
Peng LiuPeng Liu
Peng Liu
Tapani ViitalaTapani Viitala
Tapani Viitala
AKAlma Kartal-Hodzic
Alma Kartal-Hodzic
HLHuamin Liang
Huamin Liang
TLTimo J Laaksonen
Timo J Laaksonen
LPLeena Peltonen
Leena Peltonen

2 May 2025 in The AAPS Journal
Verified
Journal Article
Closed access
PDF file
XWXiaofeng Wang
Xiaofeng Wang
LLLongjie Li
Longjie Li
HYHongyi Yang
Hongyi Yang
QHQingfeng He
Qingfeng He
XZXiao Zhu
Xiao Zhu
XXXiaoqiang Xiang
Xiaoqiang Xiang

4 June 2025 in The AAPS Journal
Verified
Journal Article
Closed access
XWXiaofeng Wang
Xiaofeng Wang
LLLongjie Li
Longjie Li
HYHongyi Yang
Hongyi Yang
QHQingfeng He
Qingfeng He
XZXiao Zhu
Xiao Zhu
XXXiaoqiang Xiang
Xiaoqiang Xiang